Gaviscon and Systemic lupus erythematosus - a phase IV clinical study of FDA data

Summary:

Systemic lupus erythematosus is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Omeprazole, and have Crohn's disease.

The phase IV clinical study analyzes which people have Systemic lupus erythematosus when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,088 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

On Jul, 26, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 45 people (0.38%) have Systemic lupus erythematosus.

Could Gaviscon cause Systemic lupus erythematosus?

Among these 45 people:

How long have people been on Gaviscon when they have Systemic lupus erythematosus? *

What is the gender of people who have Systemic lupus erythematosus when taking Gaviscon? *

female: 65.12 %
male: 34.88 %

What is the age of people who have Systemic lupus erythematosus when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

What are other side effects people have besides Systemic lupus erythematosus? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 40 people, 88.89%
Drowsiness: 39 people, 86.67%
Headache (pain in head): 37 people, 82.22%
Hypopnea: 35 people, 77.78%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 35 people, 77.78%
Haematochezia (passage of stools containing blood): 35 people, 77.78%
Gingival Pain (gum pain): 35 people, 77.78%
Fever: 35 people, 77.78%
Fatigue (feeling of tiredness): 35 people, 77.78%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 35 people, 77.78%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 35 people, 77.78%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 34 people, 75.56%
Ill-Defined Disorder: 34 people, 75.56%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 34 people, 75.56%
High Blood Pressure: 32 people, 71.11%
Gastritis (inflammation of stomach): 32 people, 71.11%
Dyscalculia (impaired ability to learn grade-appropriate mathematics): 22 people, 48.89%
High Blood Cholesterol: 19 people, 42.22%
Cardiac Failure Chronic: 19 people, 42.22%
Adverse Drug Reaction: 17 people, 37.78%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Systemic lupus erythematosus?

- Check whether Systemic lupus erythematosus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Systemic lupus erythematosus treatments and more:

Systemic lupus erythematosus (76,947 reports)

How severe was Systemic lupus erythematosus and when was it recovered:

Systemic lupus erythematosus in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Systemic lupus erythematosus and drugs with ingredients of aluminum hydroxide; magnesium trisilicate (54 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Systemic lupus erythematosus:

Systemic lupus erythematosus (1,088 drugs)

Browse all the conditions that are associated with Systemic lupus erythematosus:

Systemic lupus erythematosus (1,643 conditions)

Related publications that referenced our studies

Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.